← Devices & Neurotechnology
Details checkedClinical trial listing onlyCheckedregistry
Hearing-impairment exome sequencing study
Also known as: Exome Sequencing, Exome analysis in hearing impaired patients
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Genetic/Diagnostic Sequencing
Stage
Not applicable
Status
Unknown
Target Gene
—
Route / Mode
Exome sequencing
Confidence
84%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
France
Population
genetic, familial, pediatric, adult
Trial IDs
1
Mechanism
Retrospective family-based exome sequencing study to identify molecular causes of familial hearing impairment after known deafness genes had been excluded.
Indications
Notes
Registry-verified diagnostic sequencing study. This was generated as gene therapy, but the intervention is sequencing/diagnosis, not treatment.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT03557879
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencegenetic-testing-not-gene-therapydiagnostic-study-not-productcurrent-status-unknown-in-registrywas-therapeutic-misclassification
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed